GFAP and early-onset autosomal dominant Alzheimer disease: Glial fibrillary acidic protein (GFAP), a structural protein and marker of astroglial integrity, is differentially expressed in various pathologies: elevated in neuroinflammatory conditions, including Alzheimer’s disease and epilepsy, and attenuated in neuropsychiatric disorders such as major depressive disorder [14].